Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MAPP > SEC Filings for MAPP > Form 8-K on 21-Nov-2012All Recent SEC Filings

Show all filings for MAP PHARMACEUTICALS, INC.

Form 8-K for MAP PHARMACEUTICALS, INC.


21-Nov-2012

Other Events


Item 8.01. Other Events

On November 21, 2012, MAP Pharmaceuticals, Inc. (the "Company") announced that the Company's resubmitted New Drug Application ("NDA") for LEVADEX® orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Exhibit No. Description
99.1 Press Release dated November 21, 2012


  Add MAPP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MAPP - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.